Cargando…
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy
AIMS: The role of adoptive immunotherapy (AIT) for patients with hepatocellular carcinoma (HCC) who have received curative therapy is still not well illustrated. This timely meta-analysis aims to update the current evidence on efficacy and safety of AIT for patients with HCC who have received curati...
Autores principales: | Mo, Han-Yue, Liao, Ying-Yang, You, Xue-Mei, Cucchetti, Alessandro, Yuan, Bao-Hong, Li, Ru-Hong, Zhong, Jian-Hong, Li, Le-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365130/ https://www.ncbi.nlm.nih.gov/pubmed/28339493 http://dx.doi.org/10.1371/journal.pone.0174222 |
Ejemplares similares
-
Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review
por: Yuan, Bao-Hong, et al.
Publicado: (2017) -
Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
por: Mo, Han-Yue, et al.
Publicado: (2016) -
Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment
por: Liu, Lian-Feng, et al.
Publicado: (2018) -
Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019) -
Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Cucchetti, Alessandro, et al.
Publicado: (2016)